Hearing Loss Clinical Trials

Find Hearing Loss Clinical Trials Near You

Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other, Genetic
Study Type: Observational
SUMMARY

The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 30
Maximum Age: 55
Healthy Volunteers: f
View:

• Female or Male patients ≥30 and ≤55 years old

• Bilateral hearing loss first noticed after the age of 16 years old

• Documented genotyping results showing mutations in GJB2 gene.

Locations
United States
Florida
The University of South Florida Board of Trustees
RECRUITING
Tampa
Other Locations
France
CHU Gui de Chauliac
RECRUITING
Montpellier
Contact Information
Primary
Lionel HOVSEPIAN, MD
lionel.hovsepian@sensorion-pharma.com
+33786311376
Backup
Géraldine HONNET, MD
geraldine.honnet@sensorion-pharma.com
Time Frame
Start Date: 2024-06-14
Estimated Completion Date: 2027-07
Participants
Target number of participants: 100
Treatments
Patients with adulthood-onset bilateral sensorineural hearing loss (SNHL)
Patients that carry mutations in the gene GJB2 from patients with adulthood-onset bilateral SNHL
Related Therapeutic Areas
Sponsors
Leads: Sensorion

This content was sourced from clinicaltrials.gov